Tower Research Capital LLC (Trc) Tiziana Life Sciences LTD Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 428 shares of TLSA stock, worth $398. This represents 0.0% of its overall portfolio holdings.
Number of Shares
428Holding current value
$398% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding TLSA
# of Institutions
32Shares Held
1.94MCall Options Held
19.2KPut Options Held
0-
Sanctuary Advisors, LLC Indianapolis, IN908KShares$844,0800.01% of portfolio
-
Geode Capital Management, LLC Boston, MA219KShares$203,3730.0% of portfolio
-
Hsbc Holdings PLC London, X0115KShares$107,2890.0% of portfolio
-
Morgan Stanley New York, NY110KShares$102,0640.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il104KShares$96,9900.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $95.1M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...